Houlihan Financial Resource Group’s iShares iBonds Dec 2032 Term Corporate ETF IBDX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$3.34M Buy
132,540
+28,490
+27% +$718K 1.19% 30
2026
Q1
$2.63M Buy
104,050
+37,950
+57% +$968K 1.02% 32
2025
Q4
$1.69M Buy
+66,100
New +$1.69M 0.64% 42

Other funds holding IBDX

Houlihan Financial Resource Group's IBDX Position: Q2 2026 in Review

Houlihan Financial Resource Group increased its iShares iBonds Dec 2032 Term Corporate ETF (IBDX) stake by 27% in Q2 2026, buying an estimated $718K and bringing the position to 132,540 shares worth $3.34M. The position accounts for 1.19% of the portfolio, ranked #30.

Houlihan Financial Resource Group first reported a position in IBDX in Q4 2025 and has held it in 3 quarters since. 228 funds tracked by Wall St. Rank hold IBDX as of Q2 2026.

  • Houlihan Financial Resource Group held 132,540 shares of iShares iBonds Dec 2032 Term Corporate ETF worth $3.34M as of Q2 2026.
  • Houlihan Financial Resource Group bought 28,490 iShares iBonds Dec 2032 Term Corporate ETF shares in Q2 2026, an estimated $718K.
  • iShares iBonds Dec 2032 Term Corporate ETF made up 1.19% of Houlihan Financial Resource Group's portfolio in Q2 2026, its #30 holding.
  • Houlihan Financial Resource Group first reported a position in iShares iBonds Dec 2032 Term Corporate ETF in Q4 2025 and has held it in 3 quarters since.
  • 228 funds tracked by Wall St. Rank held iShares iBonds Dec 2032 Term Corporate ETF as of Q2 2026.

Based on Houlihan Financial Resource Group's 13F filing for Q2 2026, filed 10 Aug 2026.